Searchable abstracts of presentations at key conferences in endocrinology

ea0031p1 | Bone | SFEBES2013

GNA11 loss-of-function mutations cause familial hypocalciuric hypercalcaemia type 2 (FHH2)

Hannan Fadil , Nesbit M A , Howles Sarah , Babinsky Valerie , Cranston Treena , Rust Nigel , Hobbs Maurine , Heath III Hunter , Thakker Rajesh

Loss-of-function mutations of the calcium-sensing receptor (CaSR), a G-protein-coupled receptor (GPCR), result in familial hypocalciuric hypercalcaemia (FHH), a disorder of extracellular calcium homeostasis affecting the parathyroids and kidneys. However, around 35% of FHH patients do not have CaSR mutations. A form of FHH, designated FHH2, has been mapped to chromosome 19p. The GNA11 gene, encoding G-protein α11 (Gα11), a component of the CaSR sign...